Want to see HK:8161 full AI Analyst Report?
MediNet Group Ltd. (8161) AI Stock Analysis
Top Page
MediNet Group Ltd.
(HKEX:8161)
The score is held back primarily by weak financial performance, driven by the recent revenue drop, margin collapse, and a return to losses, with only modest balance-sheet improvement and sharply weaker free cash flow. Technicals are a partial offset with the price above major moving averages and positive MACD, though the elevated RSI suggests the move may be stretched. Valuation provides limited support because earnings are negative and no dividend yield is available.
MediNet Group Ltd. (8161) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 28.70M
- Dividend Yield
- ―
- Average Volume (3M)
- 48.33K
- Price to Earnings (P/E)
- -8.9
- Beta (1Y)
- -0.06
- Revenue Growth
- -21.61%
- EPS Growth
- -140.20%
- Country
- Hong Kong
- Employees
- 80
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
MediNet Group Ltd. Business Overview & Revenue Model
Company Description
MediNet Group Limited, an investment holding entity, delivers a wide array of medical and dental services to corporations, insurance companies, and private individuals across Hong Kong and the People's Republic of China. The company manages two MediN...
MediNet Group Ltd. Financial Statement Overview
Summary
Overall fundamentals are weak: the latest year saw a sharp revenue decline (~28%), a major gross-margin collapse (~9% from ~52%), and a return to net and operating losses. The balance sheet has improved from the 2024 leverage peak but remains meaningfully leveraged (debt-to-equity ~1.38) with negative ROE. Cash flow is the main support (positive operating and free cash flow in 2026), but it deteriorated sharply (~75% drop in free cash flow), limiting downside cushion.
Income Statement
38NegativeBalance Sheet
42NeutralCash Flow
55Neutral| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.40M | 83.40M | 106.39M | 116.25M | 110.39M | 121.07M |
| Gross Profit | 9.43M | 7.53M | 55.16M | 15.20M | 56.68M | 65.44M |
| EBITDA | 4.68M | 4.09M | 17.54M | 2.39M | -11.60M | 8.06M |
| Net Income | -3.24M | -3.24M | 8.06M | -8.08M | -24.88M | -6.22M |
Balance Sheet | ||||||
| Total Assets | 36.78M | 36.78M | 51.65M | 42.03M | 42.88M | 68.46M |
| Cash, Cash Equivalents and Short-Term Investments | 10.17M | 10.17M | 13.87M | 17.32M | 15.57M | 15.60M |
| Total Debt | 11.52M | 11.52M | 18.11M | 15.96M | 9.82M | 12.85M |
| Total Liabilities | 28.86M | 28.86M | 40.50M | 38.84M | 31.55M | 31.82M |
| Stockholders Equity | 8.37M | 8.37M | 11.60M | 3.63M | 11.76M | 36.80M |
Cash Flow | ||||||
| Free Cash Flow | 1.09M | 1.09M | 4.82M | 1.61M | 9.65M | 6.45M |
| Operating Cash Flow | 1.34M | 1.34M | 5.11M | 4.40M | 10.36M | 7.22M |
| Investing Cash Flow | 3.35M | 3.35M | 184.00K | -2.59M | -707.00K | -772.00K |
| Financing Cash Flow | -8.40M | -8.40M | -8.67M | -11.00K | -9.53M | -11.56M |
MediNet Group Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8161, the sentiment is Positive. The current price of 0.69 is above the 20-day moving average (MA) of 0.60, above the 50-day MA of 0.52, and above the 200-day MA of 0.57, indicating a bullish trend. The MACD of 0.05 indicates Negative momentum. The RSI at 71.56 is Negative, neither overbought nor oversold. The STOCH value of 94.59 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8161.
MediNet Group Ltd. Peers Comparison
Overall Rating
HK:237379Outperform
HK:213555Neutral- HK:816151Neutral
HK:663948Neutral
HK:388641Neutral
HK:830737Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:2373 | 79Outperform | HKD 4.17B | 8.81 | 31.63% | 4.33% | 22.71% | 43.58% |
| HK:2135 | 55Neutral | HKD 62.39M | 3.94 | 12.17% | ― | 36.68% | ― |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:8161 | 51Neutral | HKD 28.70M | -8.86 | -32.49% | ― | -21.61% | -140.20% |
| HK:6639 | 48Neutral | HKD 1.03B | 31.06 | 1.27% | ― | ― | ― |
| HK:3886 | 41Neutral | HKD 1.10B | 78.09 | 0.48% | 1.10% | -3.26% | ― |
| HK:8307 | 37Underperform | HKD 60.30M | 64.28 | 19.79% | ― | 6.13% | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:8161 | MediNet Group Ltd. | 0.69 | 0.09 | 15.00% | |
| HK:2135 | Raily Aesthetic Medicine International Holdings Limited | 0.11 | -0.00 | -3.45% | |
| HK:2373 | Beauty Farm Medical & Health Industry, Inc. | 16.62 | -12.33 | -42.60% | |
| HK:3886 | Town Health International Medical Group Ltd. | 0.16 | -0.11 | -40.07% | |
| HK:6639 | Arrail Group Ltd. | 1.83 | -0.09 | -4.74% | |
| HK:8307 | Medicskin Holdings Ltd. | 0.15 | -0.03 | -15.56% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 17, 2026